https://www.mobilememory.app/

https://people.brandeis.edu/~bxu/

Speakers:

Irena Ivanovska

Irena Ivanovska, Ph.D. is a Director at Celdara Medical, where she leads several internal therapeutic development programs. In addition, she serves as an Alliance Manager in support of Celdara’s Pipeline Development Service partnerships with pharmaceutical companies. She also leads Celdara’s due diligence efforts for reviewing new opportunities.

Chari Smith

Dr. Chari Smith is the founder and principal consultant for PharmTeam Consulting, providing consulting services for preclinical drug discovery programs with a focus on programs emerging from Academic environments. Dr. Smith is an accomplished biochemist, with over 25 years of experience in the pharmaceutical industry. In addition to her work with PharmTeam Consulting, Dr. Smith has served as the Drug Discovery Consultant in Residence at Princeton University, Princeton, NJ, where she provided on-site consulting for university researchers seeking entrepreneurial opportunities and consults with the Dean of Research office on creating external partnerships between the university and the biotechnology industry. She continues to consult with the university in this capacity.

Anne Joseph

Anne Joseph is the Product Development and Commercialization (PDC) Senior Manager at Biogen. As PDC Senior Manager, she works in close partnership with the PDC Lead and drives asset strategy, implementation plans, analyses and progress for BIIB111 CHM & BIIB112 RPGR. Previously, she was the Search and Evaluation Manager for the External Portfolio Innovation Unit at Biogen. She has also been a Life Sciences Consultant for Back Bay Life Sciences Advisors. She received her Ph.D. in Neuroscience from Brandeis University in 2017 and her thesis investigated the contribution of specific calcium-dependent signaling pathways in the maintenance of firing rate homeostasis of the neuron. Using Ca imaging, immunohistochemistry and electrophysiology she probed into the CaMKIV pathway in pyramidal rat neurons.

Alexander Margulis

Dr. Margulis is currently leveraging his scientific and business acumen to manage the operations and business development at Mansfield Bio-Incubator. Concurrently, he is working as a Business Development Manager (New England) in a boutique life science and marketing strategy organization. Previously, while working at Precision Biosystems where he developed and executed a strategy to increase the sales by 100% within 1 year while managing a team of manufacturer's representatives. Beforehand, he worked as a Senior Scientist at BIOARRAY Therapeutics, where he managed the project to set up a fully functional laboratory 33% ahead of schedule while saving money and developed proof-of-concept assays for the company's leading diagnostic test. Prior to that, Dr. Margulis worked for 7 years in large biotech/pharma companies in project teams to perform cell-based assays.

The skills you gained through your PhD can help you thrive in a recession. We have all heard that the PhD job market was challenging even during the economic boom, so what about now, in the recession? Skills developed while earning a PhD can actually give doctoral degree holders an advantage during challenging economic times. Learn how to leverage your strengths as an academically-trained, highly-skilled worker in this practical session. You’ll learn what you have in your skill set as a PhD and what extra preparation you will need to thrive-and how to get that preparation.

The speakers featured:

David Waterman

David Waterman (PhD '18) is a dual-career scientist and entrepreneur, a PhD recipient from Brandeis and a SPROUT and I-CORPS alumnus. While in graduate school, David founded GreenLabs Recycling, a locally owned and operated lab plastic recycling company that services academic, pharma and biotech labs in the Greater Boston Area. Together with the team at GreenLabs Recycling, David turned a world-wide problem in plastic waste into a rapidly-growing business. When not recycling plastic, David can be found in the lab at MIT’s Koch Institute of Integrative Cancer Research where he studies how healthy cells develop into cancers. David has been tapped as a consultant for companies specializing in drug development and advises lab facilities on innovative ways to meet their sustainability goals.

Nathan Cohen

Dr. Nathan Cohen is the CEO of Fractal Antenna Systems of Bedford, Massachusetts. He is a physicist and radio astronomer with a background in electromagnetics, fractal geometry, and imaging. A graduate of Brandeis University, he received an M.S. and Ph.D. from Cornell University and has held research or professorial positions at Harvard, MIT, Cornell, and Boston Universities, Arecibo Observatory, and NASA (JPL and Ames). He holds 64 U.S. utility patents, and 50 pending patents, including ‘source’ patents on fractal antennas, fractal resonators, metamaterial lenses, invisibility cloaks and deflector shields, fractal metamaterials and radiative transfer, fractal batteries, fractal electromagnets, fractal absorbers, cancer treatments, superconductivity, autonomous road navigation, and 3D printing. He is recognized as a leading world authority on these and related subjects. He has published over 100 technical articles and four books and is a Fellow of the Radio Club of America where he was awarded the Lee DeForest Award for substantial contributions to radio/wireless communications.

Domenico Bullara

Domenico Bullara is a Nonlinear Chemist currently working as Quantitative System Pharmacologist for the Novartis Institute of Biomedical Research. His expertise is in developing and analyzing mathematical models for the dynamical behavior of complex chemical and biological systems. Before his current focus on biochemical modelling for drug discovery, he has extensively worked in the field of spatiotemporal pattern formation in nonlinear chemistry during his PhD years at the Université Libre de Bruxelles and his postdoctoral appointment at Brandeis University.

Illana Goldberg

Dr. Ilana Goldberg joined the National Institute of Biomedical Imaging and Bioengineering (NIBIB) in 2019 as a AAAS Science & Technology Policy Fellow. She currently has oversight of discovery and research grants with an emphasis on biophotonics. Dr. Goldberg earned her B.S. degree from Brandeis University in Chemistry and Biochemistry, where she gained expertise in protein crystallography. She earned her Ph.D. degree from Georgetown University in solid state and analytical chemistry where she focused on the crystal growth of secondary explosives. In 2005 she was awarded a Fulbright Fellowship to study crystal engineering, polymorphism, and co-crystallization of small molecules at Ben Gurion University in Be’er Sheva, Israel.